Cuba’s Soberana 02 to complement its 3rd phase in Iran

Tehran, Apr 20 (Prensa Latina) Cuba's vaccine candidate against Covid-19, Soberana 02, will soon begin the complementary studies of the 3rd phase clinical trials in Iran, according to the Pasteur Institute of that country.

April 20, 2021
00:30

Such product will reach 24,000 volunteers in seven provinces in the north, center and south of the country; and in two of those territories a third booster dose will be applied, explained the director of the entity, Alireza Biglari, to the local ISNA news agency.

‘The third dose can be effective in boosting the immunity of people who have previously been infected with Covid-19,’ he noted.

The director added that, if that stage proves successful, Cuba’s Soberana 02 could be used in general vaccination in Iran.

Eight universities of Medical Sciences in the Iranian provinces of Mazandaran, Babol, Isfahan, Yazd, Kerman, Hormozgan, Zanyan and Hamedan will participate in the trials.

rly/omr/ga/cdg